Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Passage BIO, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +6 vs. Q4 2025
- Shares held
- 1.78M
- +329.3K (+22.7%) vs. Q4 2025
- Total value
- $13.8M
- −$3.29M (−19.2%) vs. Q4 2025
- New holders
- 12
- 6 more added
- Sold out
- 6
- 4 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 623,704 | $4.90M | 0.77% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 305,000 | $2.39M | 0.07% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 133,612 | $1.05M | 0.00% | +24,523+22.5% | Added |
| Eversept Partners, LP | 131,581 | $1.03M | 0.07% | +5,351+4.2% | Added |
| Vanguard Capital Management LLC | 113,964 | $894.6K | 0.00% | +113,964 | New |
| Yiheng Capital Management, L.P. | 86,097 | $675.9K | 0.29% | +51,796+151.0% | Added |
| Ikarian Capital, LLC | 68,124 | $534.8K | 0.08% | +68,124 | New |
| Erste Asset Management GmbH | 85,262 | $526.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 41,380 | $324.9K | 0.00% | +9,983+31.8% | Added |
| BlackRock, Inc. | 28,595 | $224.5K | 0.00% | −308−1.1% | Reduced |
| UBS Group AG | 27,501 | $215.9K | 0.00% | +26,059+1,807.1% | Added |
| Acadian Asset Management LLC | 24,196 | $189.0K | 0.00% | 00.0% | Unchanged |
| Verdad Advisers, LP | 22,128 | $173.7K | 0.20% | +22,128 | New |
| Diadema Partners LP | 19,530 | $153.3K | 0.06% | +19,530 | New |
| Boothbay Fund Management, LLC | 18,871 | $148.1K | 0.00% | +18,871 | New |
| Vanguard Fiduciary Trust Co | 17,049 | $133.8K | 0.00% | +17,049 | New |
| XTX Topco Ltd | 12,627 | $99.1K | 0.00% | +12,627 | New |
| Fiduciary Trust Co | 10,750 | $84.4K | 0.00% | 00.0% | Unchanged |
| Persistent Asset Partners Ltd | 4,955 | $38.9K | 0.02% | +4,955 | New |
| Morgan Stanley | 2,650 | $20.8K | 0.00% | −1,625−38.0% | Reduced |
| Rockefeller Capital Management L.P. | 800 | $6.28K | 0.00% | +300+60.0% | Added |
| Vanguard Global Advisers, LLC | 638 | $5.01K | 0.00% | +638 | New |
| Tower Research Capital LLC (TRC) | 502 | $3.94K | 0.00% | +502 | New |
| Barclays PLC | 212 | $1.66K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 124 | $973 | 0.00% | −18−12.7% | Reduced |
| Wells Fargo & Company | 115 | $903 | 0.00% | +115 | New |
| Parallel Advisors, LLC | 16 | $126 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 15 | $117 | 0.00% | −5−25.0% | Reduced |
| BNP Paribas Arbitrage, SA | 12 | $94 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 12 | $94 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 15 | $93 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 3 | $24 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $8 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | +2 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,660−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −14,217−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −12,578−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,799−100.0% | Sold out |
| Nano Cap New Millennium Growth Fund L P | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |